Allergan, Irvine, Calif, maker of botulinum toxin Type A and breast-implants, spent $520,000 in 2007 to lobby the federal government, according to a disclosure form.
The company lobbied on Medicare issues, according to the form posted online by the Senate’s public records office on February 15. Allergan spent $320,000 lobbying on those issues in the second half of 2007.
Lobbyists are required to disclose activities that could influence members of the executive and legislative branches, under a federal law enacted in 1995.
[Associated Press, February 25, 2008]